Recent Research | Page 77 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Titlesort ascending Original Publication Date Journal Bone Marrow Disease
A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome. Apr 2012 Ann Hematol. aplastic anemia
A Prospective Multicenter Study of Paroxysmal Nocturnal Hemoglobinuria Cells in Patients with Bone Marrow Failure. Oct 2013 Cytometry B Clin Cytom paroxysmal nocturnal hemoglobinuria (PNH)
A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure. Nov 2013 Cytometry B Clin Cytom paroxysmal nocturnal hemoglobinuria (PNH)
A promising new treatment for refractory aplastic anemia Jul 2012 N Engl J Med aplastic anemia
A Primary Care Approach to Myelodysplastic Syndromes May 2014 Korean J Fam Med myelodysplastic syndromes (MDS)
A plasma microRNA signature as a biomarker for acquired aplastic anemia Sep 2016 Haematologica aplastic anemia
A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure Oct 2014 Leuk Res myelodysplastic syndromes (MDS)
A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes Jun 2017 Leukemia myelodysplastic syndromes (MDS)
A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia Oct 2016 Br J Haematol myelodysplastic syndromes (MDS)
A Phase 1 Study of Oral ARRY-614, a p38 MAPK/Tie2 Dual Inhibitor, in Patients with Low or Intermediate 1 Risk Myelodysplastic Syndromes Dec 2014 Clin Cancer Res myelodysplastic syndromes (MDS)